Prevalence of migraine subtypes in women with endometriosis and/or dysmenorrhea: results from a cross-sectional multicenter trial

Migraine and endometriosis are both debilitating chronic pain conditions that frequently co-occur in women. We aimed to assess the prevalence of migraine in women with surgically confirmed endometriosis (SCE) compared to women without surgically confirmed endometriosis (non-SCE), and to explore the distribution of migraine subtypes in this population. In a cross-sectional multicenter study, 838 women were recruited from two endometriosis centers and a patient association. Participants completed a standardized online questionnaire assessing migraine phenotype (ICHD-3 criteria), endometriosis status (surgically confirmed or not), and current hormone therapy. Group comparisons were performed using statistical tests, and odds ratios (OR) with 95% confidence intervals (CI) were calculated. Surgically confirmed endometriosis (SCE) was present in 561 participants (67%), whereas 277 (33%) had no surgical confirmation (non-SCE). A total of 320 (38.2%) participants reported migraine. Migraine was more prevalent in women with SCE than in those without (41.0% vs. 32.5%; OR 1.44, 95% CI 1.07–1.95), and remained associated after adjustment for age, BMI, education, and hormonal therapy (adjusted OR 1.38, p = 0.048). Among those with migraine, 204 (63.8%) had non-menstrual migraine (NM), 93 (29.1%) had menstrually-related migraine (RM) and 23 (7.2%) had pure menstrual migraine (PM). Migraine with aura showed higher odds in the SCE group (OR 1.61, 95% CI 1.11–2.35), as did PM (OR 11.27, 95% CI 1.51–84.01). RM was associated with higher migraine frequency (p < 0.001), pain intensity (p = 0.019), and greater functional impairment (p < 0.001) than NM or PM. Participants with PM had lower rates of endocrine endometriosis/dysmenorrhea treatments (17.4% vs. 54.4% (NM) vs. 34.4% (RM); p < 0.001). Women with SCE show a higher prevalence of migraine – particularly migraine with aura and PM – than those without SCE. The observed co-occurrence of endometriosis and migraine highlights the need for increased clinical awareness and further prospective studies to explore implications for interdisciplinary management. However, no causality can be inferred from this cross-sectional study.

Authors

Institutions

Publication Details

Journal
BMC Women s Health
Published
2026-02-13
DOI
https://doi.org/10.1186/s12905-026-04335-z
Primary Topic
Migraine and Headache Studies
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Prevalence of migraine subtypes in women with endometriosis and/or dysmenorrhea: results from a cross-sectional multicenter trial

Achim Rody, Carl Hartmut Göbel, Norbert Brüggemann, Christoph Cirkel et al.
BMC Women s Health
Migraine and Headache Studies
article

Prevalence of migraine subtypes in women with endometriosis and/or dysmenorrhea: results from a cross-sectional multicenter trial

Achim Rody, Carl Hartmut Göbel, Norbert Brüggemann, Christoph Cirkel, Anna Cirkel, Hartmut Göbel, Ibrahim Alkatout
article en

Abstract

Migraine and endometriosis are both debilitating chronic pain conditions that frequently co-occur in women. We aimed to assess the prevalence of migraine in women with surgically confirmed endometriosis (SCE) compared to women without surgically confirmed endometriosis (non-SCE), and to explore the distribution of migraine subtypes in this population. In a cross-sectional multicenter study, 838 women were recruited from two endometriosis centers and a patient association. Participants completed a standardized online questionnaire assessing migraine phenotype (ICHD-3 criteria), endometriosis status (surgically confirmed or not), and current hormone therapy. Group comparisons were performed using statistical tests, and odds ratios (OR) with 95% confidence intervals (CI) were calculated. Surgically confirmed endometriosis (SCE) was present in 561 participants (67%), whereas 277 (33%) had no surgical confirmation (non-SCE). A total of 320 (38.2%) participants reported migraine. Migraine was more prevalent in women with SCE than in those without (41.0% vs. 32.5%; OR 1.44, 95% CI 1.07–1.95), and remained associated after adjustment for age, BMI, education, and hormonal therapy (adjusted OR 1.38, p = 0.048). Among those with migraine, 204 (63.8%) had non-menstrual migraine (NM), 93 (29.1%) had menstrually-related migraine (RM) and 23 (7.2%) had pure menstrual migraine (PM). Migraine with aura showed higher odds in the SCE group (OR 1.61, 95% CI 1.11–2.35), as did PM (OR 11.27, 95% CI 1.51–84.01). RM was associated with higher migraine frequency (p < 0.001), pain intensity (p = 0.019), and greater functional impairment (p < 0.001) than NM or PM. Participants with PM had lower rates of endocrine endometriosis/dysmenorrhea treatments (17.4% vs. 54.4% (NM) vs. 34.4% (RM); p < 0.001). Women with SCE show a higher prevalence of migraine – particularly migraine with aura and PM – than those without SCE. The observed co-occurrence of endometriosis and migraine highlights the need for increased clinical awareness and further prospective studies to explore implications for interdisciplinary management. However, no causality can be inferred from this cross-sectional study.

BMC Women s HealthVol. 26(1)
University Hospital Schleswig-Holstein (DE), Clinical Research Center Kiel (DE), University of Lübeck (DE)
Openalex Percentile: Top 61%
Migraine and Headache Studies
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.